- Oppenheimer cut Amdocs to Perform from Outperform.
- No target price or rationale was included.
- Oppenheimer lowered its rating on Amdocs to Perform from Outperform.
Oppenheimer downgraded Amdocs to Perform from Outperform. The move removes the firm's prior outperform stance on the company. No target price or rationale was disclosed.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.